This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Which Performs Better In Retirement Sp 500 Or Multi Asset
This piece evaluates performance in retirement for Sp 500 vs Multi Asset approaches, outlining where each may excel under different conditions.
26,383 articles
Rising Demand Rare Precious Metals Meets 24/7 Access
A fresh web app enables 24/7 ownership of tokenized rare metals, including gold and uranium, with vault-backed receip...
Archer Aviation's Liftoff Stalled by Its $700 Million Cash Burn
Archer Aviation faces a critical cash burn challenge as it works toward FAA certification and commercial revenues. Th...
Minnesota Fraudster $250 Million Case Drives Sentencing
A Minnesota nonprofit leader was sentenced to nearly 42 years for orchestrating a $250 million fraud tied to pandemic...
Here Tuesday’s Wall Street Analyst Calls Move Big Names
Tuesday’s market action centers on fresh analyst calls for Albemarle, Booz Allen Hamilton, Cigna, DT Midstream, GE Ve...
Kalshi Adds Perpetual Futures for U.S. Traders, Regulator OK
U.S.-based Kalshi gains regulatory clearance to offer Bitcoin perpetual futures, bringing expiry-free leverage to Ame...
Crypto Industry Launches Focused PAC to Protect Developers
A new PAC targets software developers with policy safeguards as the 2026 midterms loom. It pledges to back candidates...
Trump Says Iran Deal Nearing Completion, Bitcoin Rises
Bitcoin climbs after Trump suggests an Iran deal is near, sparking a risk-on move in crypto markets. Prices hit aroun...
Closed Fund Quietly Returning 15% Beats Bond Yields
A niche ETF that targets closed-end funds is delivering roughly 15% total return over the past year, while its holdin...
Financing That Keeps Starter Homes Within Reach in 2026
In a week-long burst of closings, six starter units priced at $90k-$140k sold, five via seller financing. The episode...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Defections From Google DeepMind Roil the AI Race Ahead
Two senior DeepMind researchers left within 48 hours, jolting Alphabet's AI strategy and sending shockwaves through t...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status